MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced its financial results for the year ended December 31, 2006. For the full year, revenues totaled $9.6 million, compared to $4.4 million reported for the full year 2005. Cash, cash equivalents and marketable securities at December 31, 2006 were $33.6 million.
